|
1
|
Joint United Nations Program on HIV/AIDS
(UNAIDS) and World Health Organization (WHO): AIDS Epidemic Update.
UNAIDS; Geneva: 2003
|
|
2
|
Heaton RK, Clifford DB, Franklin DR Jr, et
al: HIV-associated neurocognitive disorders persist in the era of
potent antiretroviral therapy: CHARTER Study. Neurology.
75:2087–2096. 2010. View Article : Google Scholar
|
|
3
|
Robertson KR, Smurzynski M, Parsons TD, et
al: The prevalence and incidence of neurocognitive impairment in
the HAART era. AIDS. 21:1915–1921. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Simioni S, Cavassini M, Annoni JM, et al:
Cognitive dysfunction in HIV patients despite long-standing
suppression of viremia. AIDS. 24:1243–1250. 2010.PubMed/NCBI
|
|
5
|
Pumpradit W, Ananworanich J, Lolak S, et
al: Neurocognitive impairment and psychiatric comorbidity in
well-controlled human immunodeficiency virus-infected Thais from
the 2NN Cohot Study. J Neurovirol. 16:76–82. 2010. View Article : Google Scholar
|
|
6
|
Sacktor N, McDermott MP, Marder K, et al:
HIV-associated cognitive impairment before and after the advent of
combination therapy. J Neurovirol. 8:136–142. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gorman AA, Foley JM, Ettenhofer ML, Hinkin
CH and van Gorp WG: Functional consequences of HIV-associated
neuropsychological impairment. Neuropsychol Rev. 19:186–203. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Antinori A, Arendt G, Becker JT, et al:
Updated research nosology for HIV-associated neurocognitive
disorders. Neurology. 69:1789–1799. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nomenclature and research case definitions
for neurological manifestations of human immunodeficiency virus
type-1 (HIV-1) infection. Report of a Working Group of the American
Academy of Neurology AIDS Task Force. Neurology. 41:778–785. 1991.
View Article : Google Scholar
|
|
10
|
Folstein MF, Folstein SE and McHugh PR:
Mini-mental state. A practical method for grading the cognitive
state of patients for the clinician. J Psychiatr Res. 12:189–198.
1975.
|
|
11
|
Bleecker ML, Bolla-Wilson K, Kawas C and
Agnew J: Age-specific norms for the Mini-Mental State Exam.
Neurology. 38:1565–1568. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sacktor NC, Wong M, Nakasujja N, et al:
The International HIV Dementia Scale: a new rapid screening test
for HIV dementia. AIDS. 19:1367–1374. 2005.PubMed/NCBI
|
|
13
|
Singh D, Sunpath H, John S, Eastham L and
Gouden R: The utility of a rapid screening tool for depression and
HIV dementia amongst patients with low CD4 counts - a preliminary
report. Afr J Psychiatry (Johannesbg). 11:282–286. 2008.
|
|
14
|
Skinner S, Adewale AJ, DeBlock L, Gill MJ
and Power C: Neurocognitive screening tools in HIV/AIDS:
comparative performance among patients exposed to antiretroviral
therapy. HIV Med. 10:246–252. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Joska JA, Westgarth-Taylor J, Hoare J, et
al: Validity of the International HIV Dementia Scale in South
Africa. AIDS Patient Care STDS. 25:95–101. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Power C, Selnes OA, Grim JA and McArthur
JC: HIV Dementia Scale: a rapid screening test. J Acquir Immune
Defic Syndr Hum Retrovirol. 8:273–278. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Berghuis JP, Uldall KK and Lalonde B:
Validity of two scales in identifying HIV-associated dementia. J
Acquir Immune Defic Syndr. 21:134–140. 1999.PubMed/NCBI
|
|
18
|
Smith CA, van Gorp WG, Ryan ER, Ferrando
SJ and Rabkin J: Screening subtle HIV-related cognitive
dysfunction: the clinical utility of the HIV dementia scale. J
Acquir Immune Defic Syndr. 33:116–118. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Carey CL, Woods SP, Rippeth JD, et al:
Initial validation of a screening battery for the detection of
HIV-associated cognitive impairment. Clin Neuropsychol. 18:234–248.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wojna V, Skolasky RL, McArthur JC, et al:
Spanish validation of the HIV dementia scale in women. AIDS Patient
Care STDS. 21:930–941. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lyon ME, McCarter R and D’Angelo LJ:
Detecting HIV associated neurocognitive disorders in adolescents:
what is the best screening tool? J Adolesc Health. 44:133–135.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Whiting PF, Weswood ME, Rutjes AW, Reitsma
JB, Bossuyt PN and Kleijnen J: Evaluation of QUADAS, a tool for the
quality assessment of diagnostic accuracy studies. BMC Med Res
Methodol. 6:92006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zamora J, Abraira V, Muriel A, et al:
Meta-DiSc: a software for meta-analysis of test accuracy data. BMC
Med Res Methodol. 6:312006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Choi Y, Townend J, Vincent T, et al:
Neurologic manifestations of human immunodeficiency virus-2:
dementia, myelopathy, and neuropathy in West Africa. J Neurovirol.
17:166–175. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Morgan EE, Woods SP, Scott JC, et al:
Predictive validity of demographically adjusted normative standards
for the HIV Dementia Scale. J Clin Exp Neuropsychol. 30:83–90.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bottiggi KA, Chang JJ, Schmitt FA, et al:
The HIV Dementia Scale: predictive power in mild dementia and
HAART. J Neurolsci. 260:11–15. 2007.PubMed/NCBI
|
|
27
|
von Giesen HJ, Haslinger BA, Rohe S,
Köller H and Arendt G: HIV Dementia Scale and psychomotor slowing -
the best methods in screening for neuro-AIDS. J Neuropsychiatry
Clin Neurosci. 17:185–191. 2005.PubMed/NCBI
|
|
28
|
Ganasen KA, Fincham D, Smit J, Seedat S
and Stein D: Utility of the HIV Dementia Scale (HDS) in identifying
HIV dementia in a South African sample. J Neurol Sci. 269:62–64.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
McArthur JC, Cohen BA, Selnes OA, et al:
Low prevalence of neurological and neuropsychological abnormalities
in otherwise healthy HIV-1-infected individuals: results from the
multicenter AIDS Cohort Study. Ann Neurol. 26:601–611. 1989.
View Article : Google Scholar
|
|
30
|
Sacktor NC, Bacellar H, Hoover DR, et al:
Psychomotor slowing in HIV infection: a predictor of dementia, AIDS
and death. J Neurovirol. 2:404–410. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hinkin CH, Hardy DJ, Mason KI, et al:
Medication adherence in HIV-infected adults: effect of patient age,
cognitive status, and substance abuse. AIDS. 18(Suppl 1): S19–S25.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sacktor N, Lyles RH, Skolasky RL, et al:
Combination antiretroviral therapy improves psychomotor speed
performance in HIV-seropositive homosexual men. Neurology.
52:1640–1647. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sacktor N, Skolasky RL, Lyles RH, Esposito
D, Selnes OA and McArthur JC: Improvement in HIV-associated motor
slowing after antiretroviral therapy including protease inhibitors.
J Neurovirol. 6:84–88. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pham B, Platt R, McAuley L, et al: Is
there a ‘best’ way to detect and minimize publication bias? An
empirical evaluation. Eval Health Prof. 24:109–125. 2001.PubMed/NCBI
|
